Skip to main content

Table 2 Characteristics of study participants and details regarding their sinosomatics treatment

From: Psychotherapy with somatosensory stimulation as a complementary treatment for women with endometriosis-associated pain – a qualitative study

Participant

Age (years)

Endometriosis stage (ASRM)

Maximal pelvic pain (NRS, past 3 months)

SF-12 PCS

SF-12 MCS

Number of treatments

Ongoing treatment

∆ maximal pelvic pain (NRS, past 3 months)

Perceived treatment success

P1

29

3

9

34,9

41,5

23

yes

-9,00

excellent

P2

35

4

8

47,6

47,6

15

yes

-7,00

excellent

P3

41

3

9

34,1

43

40

yes

-9,00

excellent

P4

37

2

3

58

25,8

29

no

-2,00

excellent

P5

34

2

9

47,1

24,9

25

yes

-6,00

good

P6

30

4

8

43,7

43,8

22

yes

-4,00

excellent

P7

42

3

10

36,2

50,6

20

yes

-1,00

good

P8

30

2

9

49,4

26,5

20

no

-1,00

fair

P9

40

3

5

46,5

39

34

yes

5,00

satisfactory

P10

37

2

7

37,1

51,2

36

yes

-2,00

excellent

  1. Abbreviations: ASRM, American Society for Reproductive Medicine; NRS, 11-point numeric rating scale; SF-12, 12-Item Short-Form Health Survey; PCS, Physical Component Summary score; MCS, Mental Component Summary score
  2. Note: Endometriosis stage, maximal pelvic pain, and SF-12 summary scores are based on assessments conducted before the treatment with sinosomatics. Changes (Δ) in maximal pelvic pain and perceived treatment success correspond to the 2-year follow-up of the clinical trial. Perceived treatment success was evaluated using a 5-point rating scale with the items ‘excellent’, ‘good’, ‘satisfactory’, ‘fair’, and ‘poor’